Is Palantir’s New Wave of NVIDIA‑Backed Defense and Industrial AI Deals Altering The Investment Case For Palantir Technologies (PLTR)?

• In March 2026, Palantir Technologies and partners including Ondas, World View, GE Aerospace, Centrus Energy, LG CNS, NVIDIA, and Polymarket announced a wave of collaborations applying Palantir’s AI platforms to defense, aerospace, industrial operations, sovereign AI data centers, and sports integrity monitoring.
• These agreements highlight Palantir’s push to embed its Artificial Intelligence Platform and related software as core infrastructure across high-stakes sectors, from military readiness and uranium enrichment to LG Group’s enterprise-wide AI transformation.
• We’ll now examine how Palantir’s expanded NVIDIA sovereign AI architecture shapes its existing investment narrative and future growth assumptions.

The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

Palantir Technologies Investment Narrative Recap

To own Palantir, you have to believe it can entrench AIP as core infrastructure for defense, industrial, and sovereign AI systems while justifying a premium valuation. The latest wave of alliances with Ondas, World View, GE Aerospace, Centrus, LG CNS, NVIDIA, and Polymarket appears to reinforce the key short term catalyst of continued U.S. commercial and defense momentum, but it does little to reduce the central risk that expectations are very high and heavily concentrated in the U.S.

Among the announcements, Palantir’s sovereign AI OS reference architecture with NVIDIA looks most relevant. By offering a turnkey AI data center stack across AIP, Foundry, Apollo, and NVIDIA infrastructure, Palantir is trying to make itself the default choice for governments and enterprises that need low latency, on premise, and data sovereign AI. For investors focused on catalysts, this directly ties into the thesis that Palantir can extend its U.S. strength into a broader sovereign AI data center footprint.

But while the partnerships are eye catching, investors should be aware that insider selling, concentrated U.S. exposure, and very high earnings expectations could all become more important if...

Read the full narrative on Palantir Technologies (it's free!)

Palantir Technologies' narrative projects $10.8 billion revenue and $3.6 billion earnings by 2028. This requires 40.7% yearly revenue growth and about a $2.5 billion earnings increase from $1.1 billion today.

Uncover how Palantir Technologies' forecasts yield a $185.70 fair value, a 23% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were already modeling roughly 45% annual revenue growth and US$4.9 billion in earnings by 2028, so if you buy into that view, recent sovereign AI and defense deals might look like confirmation rather than upside. Those forecasts assume Palantir keeps compressing deployment timelines and expanding margins, yet the same news could also be read as a test of whether such aggressive targets are realistic or if growth normalizes sooner.

Explore 134 other fair value estimates on Palantir Technologies - why the stock might be worth less than half the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Palantir Technologies research is our analysis highlighting 2 key rewards that could impact your investment decision.
• Our free Palantir Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Palantir Technologies' overall financial health at a glance.

Want Some Alternatives?

Our top stock finds are flying under the radar-for now. Get in early:

• Rare earth metals are the new gold rush. Find out which 29 stocks are leading the charge.
• Capitalize on the AI infrastructure supercycle with our selection of the 35 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com